17-44689723-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_144609.3(CCDC43):c.31G>T(p.Ala11Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000012 in 1,584,436 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_144609.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC43 | NM_144609.3 | c.31G>T | p.Ala11Ser | missense_variant | 1/5 | ENST00000315286.13 | NP_653210.2 | |
CCDC43 | NM_001099225.2 | c.31G>T | p.Ala11Ser | missense_variant | 1/4 | NP_001092695.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC43 | ENST00000315286.13 | c.31G>T | p.Ala11Ser | missense_variant | 1/5 | 1 | NM_144609.3 | ENSP00000323782 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152272Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000206 AC: 4AN: 194166Hom.: 0 AF XY: 0.00000952 AC XY: 1AN XY: 105062
GnomAD4 exome AF: 0.00000978 AC: 14AN: 1432164Hom.: 0 Cov.: 30 AF XY: 0.0000113 AC XY: 8AN XY: 710032
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152272Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74398
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 28, 2024 | The c.31G>T (p.A11S) alteration is located in exon 1 (coding exon 1) of the CCDC43 gene. This alteration results from a G to T substitution at nucleotide position 31, causing the alanine (A) at amino acid position 11 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at